Durable complete remission after Pembrolizumab in pretreated advanced endometrial cancer: A case report
Until recently endometrial cancer has classically been divided into two categories, type 1 estrogen-dependent and predominantly endometrioid and type 2 estrogen-independent and predominantly serous, according to etiological and morphological factors. The advent of molecular oncology has led to a new...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Inc.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |